Access to Pancreatic Cancer Treatments: Pancreatic Cancer Canada CEO Michelle Capobianco Speaks to Newstalk 1010

Michelle Capobianco, Chief Executive Officer of Pancreatic Cancer Canada, speaks with John Moore of Newstalk 1010 about the bureaucracy that prevents new treatments from reaching the Canadian public, speaking specifically about a therapy called ONIVYDE that could give patients desperately needed time but is currently delayed.